Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest Systemic lupus erythematosus Stories

2013-09-25 08:30:03

HAYWARD, Calif., Sept. 25, 2013 /PRNewswire/ -- Anthera Pharmaceuticals (NASDAQ: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, announced today that emerging data from its Phase 2b PEARL-SC study and subsequent Open-Label Extension study will be presented by Dr. Richard Furie at the 2013 Annual Scientific Meeting of the American College of Rheumatology and the Association of Rheumatology Health Professionals...

2013-09-23 00:20:42

- Anti-IL-6R Nanobody, ALX-0061, to be developed in rheumatoid arthritis and systemic lupus erythematosus GHENT, Belgium and NORTH CHICAGO, Ill., Sept. 23, 2013 /PRNewswire/ -- Ablynx [Euronext Brussels: ABLX] and AbbVie [NYSE: ABBV] today announced that they have entered into a global license agreement to develop and commercialize the anti-IL-6R Nanobody, ALX-0061, to treat inflammatory diseases. ALX-0061 is Ablynx's proprietary anti-IL-6R Nanobody that successfully completed...

2013-09-05 08:28:30

Strategy Provides Multiple Paths to Phase 3/NDA in Next 2-3 Years SOUTH SAN FRANCISCO, Calif., Sept. 5, 2013 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced its plans to focus the Company's resources on the completion of three lead clinical programs. These efforts include commencing a Phase 3 clinical study of fostamatinib, an oral SYK inhibitor, in Immune Thrombocytopenic Purpura (ITP) pending discussions with regulatory agencies. Rigel believes that...

2013-09-04 23:28:22

d'Oliveira & Associates has posted a new infographic about the alleged risks of the acne medicine Minocin. The law firm works with some of the more experienced lawyers, who are filing Minocycline lawsuits. (PRWEB) September 04, 2013 Minocycline hydrochloride is an antibiotic that has been used to treat acne for years. The FDA first approved this medicine in 1971 and now it is sold under a variety of names including akamin, dynacin, minocin, minomycin, and solodyn. According to...

2013-08-28 23:29:28

These meetings are designed to assist people with lupus and their family and friends to get connected with one another. (PRWEB) August 28, 2013 The Michigan Lupus Foundation will be holding a lupus Support Group meeting in Grand Rapids on September 16th. Meeting Details: Monday, September 16th 6:30 PM - 8:00 PM Location: Hope Lodge 129 Jefferson Avenue SE Room 201 (Second Floor Conference Room) Grand Rapids, MI 49503 These meetings are designed to assist people with lupus and their family...

2013-08-27 23:23:16

This EpiCast report (http://www.reportsnreports.com/reports/267627-epicast-report-systemic-lupus-erythematosus-epidemiology-forecast-to-2022.html ) says Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease of multifactorial origin that can affect any organ or organ systems, resulting in a broad spectrum of clinical manifestations ranging from dermatological involvement to multi-organ failure with episodes of relapses and remissions. Dallas, Texas (PRWEB) August 27, 2013 The...

2013-08-14 12:25:29

Summer Issue of Lupus Now® Magazine highlights his journey as an entertainer and public figure living with lupus WASHINGTON, Aug. 14, 2013 /PRNewswire-USNewswire/ -- As a multitalented entertainer and successful television personality and entrepreneur, Nick Cannon has a lot on his plate. The 32-year-old husband and father of two, who battles with lupus nephritis (kidney disease), took on another role: lupus awareness advocate. Cannon has used his voice and platform to raise...

2013-08-09 23:19:50

Michigan Lupus Foundation Support Group meetings are offered at no charge to anyone interested in participating. (PRWEB) August 09, 2013 Michigan Lupus Foundation Support Group meetings are offered at no charge to anyone interested in participating. The Michigan Lupus Foundation will be holding a lupus Support Group meeting in Detroit Metro East on August 28th. Meeting Details: Wednesday, August 28th 6:30pm – 8:00pm Location: Bethel Lutheran Church - Room 11 26400 Little Mack Avenue St....

2013-08-08 08:31:35

Biologic Agents, Including Rituxan and Benlysta, are Reserved for Moderate-to-Severe Cases of SLE, According to a New Report from BioTrends Research Group EXTON, Pa., Aug. 8, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that rheumatologists in the EU5 countries (France, Germany, Italy, Spain, United Kingdom) give Genentech/Biogen Idec's Rituxan and GlaxoSmithKline/Human Genome...

2013-08-01 16:30:51

WASHINGTON, Aug. 1, 2013 /PRNewswire-USNewswire/ -- The Lupus Foundation of America, the only national force devoted to solving the mystery of lupus, announced the election of two new directors to its national board of directors. They are: Joseph Arnold of Philadelphia, Pennsylvania and Kathleen Ruiz of New York City. Arnold and Ruiz, along with the other members of the board, will provide organizational leadership for the Foundation's strategic initiatives to bring national...